Guangdong Wanfang Pharmaceutical Technology

Guangdong Wanfang Pharmaceutical is a Chinese pharmaceutical company based in Foshan, Guangdong, specializing in the research, development, and large-scale manufacturing of chemical drugs. Since its acquisition in 2012, the company has operated as a wholly-owned subsidiary of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu). Its core business focuses on essential generic medicines within the cardiovascular, endocrine, and digestive therapeutic areas. Key products in its portfolio include Amlodipine Besylate for hypertension and Metformin Hydrochloride for diabetes management. The company maintains modern, GMP-certified manufacturing facilities that support the broader supply chain and distribution networks of the China Resources Group.